Novo Nordisk, U.K. institute unite to discover RA biomarkers

04/26/2012 | Genetic Engineering & Biotechnology News

Novo Nordisk and Oxford University’s Kennedy Institute of Rheumatology agreed to work together to identify biomarkers and develop drug targets for inflammatory autoimmune diseases including rheumatoid arthritis. As part of the deal, 10 Kennedy Institute researchers will receive funding from Novo Nordisk.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA